Cargando…
Connexin 43 confers chemoresistance through activating PI3K
Circumventing chemoresistance is crucial for effectively treating cancer including glioblastoma, a lethal brain cancer. The gap junction protein connexin 43 (Cx43) renders glioblastoma resistant to chemotherapy; however, targeting Cx43 is difficult because mechanisms underlying Cx43-mediated chemore...
Autores principales: | Pridham, Kevin J., Shah, Farah, Hutchings, Kasen R., Sheng, Kevin L., Guo, Sujuan, Liu, Min, Kanabur, Pratik, Lamouille, Samy, Lewis, Gabrielle, Morales, Marc, Jourdan, Jane, Grek, Christina L., Ghatnekar, Gautam G., Varghese, Robin, Kelly, Deborah F., Gourdie, Robert G., Sheng, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755794/ https://www.ncbi.nlm.nih.gov/pubmed/35022385 http://dx.doi.org/10.1038/s41389-022-00378-7 |
Ejemplares similares
-
Connexin 43-Based Therapeutics for Dermal Wound Healing
por: Montgomery, Jade, et al.
Publicado: (2018) -
The Effect of a Connexin43-Based Peptide on the Healing of Chronic Venous Leg Ulcers: A Multicenter, Randomized Trial
por: Ghatnekar, Gautam S, et al.
Publicado: (2015) -
Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine
por: Marsh, Spencer R., et al.
Publicado: (2021) -
Impact of the Controlled Release of a Connexin 43 Peptide on Corneal Wound Closure in an STZ Model of Type I Diabetes
por: Moore, Keith, et al.
Publicado: (2014) -
Functional Blockade of Small GTPase RAN Inhibits Glioblastoma Cell Viability
por: Sheng, Kevin L., et al.
Publicado: (2019)